UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation?

Human reproduction (Oxford), 2006-01, Vol.21 (1), p.175-182

2006

Volltextzugriff (PDF)

Preimplantation diagnosis with HLA typing: birth of the first double hope child in France

Journal de gynecologie, obstetrique et biologie de la reproduction, 2011-11, Vol.40 (7), p.682

2011

Volltextzugriff (PDF)

Extending preimplantation genetic diagnosis to HLA typing: the Paris experience

Gynécologie, obstétrique & fertilité, 2005-10, Vol.33 (10), p.824-827

2005

Volltextzugriff (PDF)

Contribution of genotyping for fetal sex determination in maternal serum for preimplantation genetic diagnosis of X-linked diseases

Gynécologie, obstétrique & fertilité, 2003-12, Vol.31 (12), p.1030-1035

2003

Volltextzugriff (PDF)

Preimplantation genetic diagnosis (PGD): results from a Parisian center

Journal de gynécologie, obstétrique et biologie de la reproduction, 2006-06, Vol.35 (4), p.356-372

2006

Volltextzugriff (PDF)

Growth discordance in dichorionic twin pregnancies: risk factors, diagnosis and management

Journal de gynécologie, obstétrique et biologie de la reproduction, 2002-02, Vol.31 (1 Suppl), p.2S15-2S24

2002

Volltextzugriff (PDF)

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2015-01, Vol.372 (5), p.436-446

2015

Volltextzugriff (PDF)

Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?

European journal of neurology, 2017-02, Vol.24 (2), p.237-244

2017

Volltextzugriff (PDF)

Spatial distribution of multiple sclerosis lesions in the cervical spinal cord

Brain (London, England : 1878), 2019-03, Vol.142 (3), p.633-646

2019

Volltextzugriff (PDF)

Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type

Annals of oncology, 2007-12, Vol.18 (12), p.1985-1989

2007

Volltextzugriff (PDF)

Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvant Study Group 05 Randomized Trial

Journal of clinical oncology, 2001-02, Vol.19 (3), p.602-611

By the French Adjuvant Study Group

2001

Volltextzugriff (PDF)

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer

Journal of clinical oncology, 1995-02, Vol.13 (2), p.314-322

1995

Volltextzugriff (PDF)

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin ± taxane-pretreated ovarian cancer patients

Annals of oncology, 2002-02, Vol.13 (2), p.258-266

2002

Volltextzugriff (PDF)

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

European journal of cancer (1990), 2003-02, Vol.39 (3), p.317-320

2003

Volltextzugriff (PDF)

A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors

Annals of oncology, 2008-08, Vol.19 (8), p.1465-1469

2008

Volltextzugriff (PDF)

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC

Annals of oncology, 1996-02, Vol.7 (2), p.165-171

1996

Volltextzugriff (PDF)

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1564-1571

1995

Volltextzugriff (PDF)

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3115-3124

the French Epirubicin Study Group

2000

Volltextzugriff (PDF)

Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group

European journal of cancer (1990), 1996, Vol.32 (1), p.181-182

1996

Volltextzugriff (PDF)

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer

British journal of cancer, 1996-08, Vol.74 (4), p.650-656

1996

Volltextzugriff (PDF)

Hereditary epidermolytic palmoplantar keratoderma associated with breast and ovarian cancer in a large kindred

British journal of dermatology (1951), 1987-09, Vol.117 (3), p.363-370

1987

Volltextzugriff (PDF)

Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma : experience of the french study group

Cancer chemotherapy and pharmacology, 1990-01, Vol.27 (2), p.81-84

1990

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(27)

Sprache

Englisch
(21)
Französisch
(6)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation?

Preimplantation diagnosis with HLA typing: birth of the first double hope child in France

Extending preimplantation genetic diagnosis to HLA typing: the Paris experience

Contribution of genotyping for fetal sex determination in maternal serum for preimplantation genetic diagnosis of X-linked diseases

Preimplantation genetic diagnosis (PGD): results from a Parisian center

Growth discordance in dichorionic twin pregnancies: risk factors, diagnosis and management

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Spatial distribution of multiple sclerosis lesions in the cervical spinal cord

Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability

Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type

Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvant Study Group 05 Randomized Trial

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin ± taxane-pretreated ovarian cancer patients

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer

Hereditary epidermolytic palmoplantar keratoderma associated with breast and ovarian cancer in a large kindred

Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma : experience of the french study group

Aktive Filter

Suchergebnisse filtern